Revolutionizing Cardiovascular Health and Chronic Inflammation

“Helping consumers monitor, manage/reverse cardiovascular disease and chronic inflammation, 
with a non-invasive simple 1 minute test and a patented, all organic plant based, clinically proven daily solution”
Amount Raised: $47,276 | Raise Goal: $500,400

The Problems The World Is Facing:

The Problems The World Is Facing:

Heart Disease is the #1 Killer in THE WORLD

Heart Disease is the #1 Killer in THE WORLD

With the key contributor being chronic inflammation*

With the key contributor being chronic inflammation*

Current Options - Drugs & Ineffective Supplements

Prescription Drug-Use Is at an All-Time-High 

The Supplement Market Is Growing Annually

Low-quality Omega Supplements are a Top-Seller

At-Home Health Monitoring Is a Multi-Billion Dollar Market

If blood pressure, pulse oxygen monitoring, and blood analysis told us the whole story, heart disease wouldn’t be the number one killer in the United States, with over 2000 people dying every day.

Markets We Are Targeting:

We have the ability to shake-up the largest growing healthcare markets in the world(These are just 4 of the 14 markets we can effectively target)

Minimum Investment - $100.20

Our Products and Solutions:

Personalized Precision: 
Non-invasive cardio-testing device

Max Pulse: FDA Cleared, semi-professional, non-invasive Class II Medical Device, with insurance reimbursement codes.
  • Early diagnoses of arteriosclerosis, peripheral arterial disease, and those at risk of heart disease, stroke, and other inflammatory issues.
  • ​Utilizing Photoplethysmography (PPG) to evaluate arterial elasticity (and arterial stiffness) in 3 minutes. 
  • ​Analysis of blood circulation through large arteries, small arteries, and capillaries.
  • ​Accurate estimation of "biological age" of the arteries the autonomic nervous system for measuring stress.
  • ​20+ year track record and over 200+ published studies.

Parent Essential Oils® PEOs

Vegan & Organic - Cold-Pressed Essential Fatty Acids

Vegan Friendly Version of PEOs on the left. PEO capsules are bovine gelatin based

  • 20+ Years of direct-to-consumer, doctor, and wholesale sales
  • ​Experiments and patents granted in United States & Canada.
  • ​Vegan-friendly version available. (no gelatin capsule)
  • Proven to reverse cardiovascular plaque in experiments.*
*https://aging-matters.com/the-power-of-the-parent-essential-oils-the-peo-solution

EZTREK™ - The Medical Food

Plant-Based and Organic - Cold-Pressed Essential Fatty Acids

The First-of-Its-Kind, Patented, Organic Medical Food for the management of an Impaired Delta-6 Desaturase Pathway.

The patented medical food, EZTREK™ has been shown to provide relief to those with chronic inflammatory diseases from a Delta-6 Desaturase Pathway impairment. Only available under the care of a licensed physician.

  • Specific dietary management for chronic inflammation*
  • Compensates for an impaired Delta-6 Desaturase Pathway*
  • Granted patents in the United States and Canada 
  • ​20+ years in development, following our D2C product "PEOs"

(EZTREK™ is a plant-based, polyunsaturated oil that is used with a  simple measuring spoon to dose patients correctly)

*Loss of delta-6-desaturase activity as a key factor in aging –September 1981 –
https://www.sciencedirect.com/science/article/abs/pii/0306987781900645

Reviews From Happy Oxygen4Life™, Inc. Customers:

Use the arrows to cycle testimonials
CUSTOM JAVASCRIPT / HTML

What Doctors Say About Our Products:

- Robert L. Kagan (Nuclear Medicine Specialist)

"I previously wrote you about the remarkable cause / effect relationship in reversing plaque volume in a (smoking) patient taking conventional treatment (i.e. statins, aspirin, Co-Q10, etc.). In reading over the patients scans, I have never seen such a remarkable result. When he [the patient] stopped taking PEOs, the plaque came back!"

- Brian N. Vonk, M.D. (Board certified: Internist, Cardiologist, Radiologist)

"Impeccable research and novel insights of sheer genius. This knowledge is priceless for your future health.”

- Kelvin Lindgren, M.D. (Otolaryngologist/ENT)

"Thanks to you and your discovery of PEOs, he (the patient) is back to playing golf, walking the course. All medical professionals need to know about the science behind this product."

- Clive Fields, M.D. (Family Practice)

"The most thoroughly researched nutritional anticancer program that I have ever seen. My patients have also noticed their energy levels have skyrocketed..."

- Angelo A. Della Pietra, M.D., D.O. (Family & Integrative Medicine)

"Physicians and their patients around the world owe you a big ‘thank you.’... I am strongly recommending this information to all my patients.”

- Steve Helschien, D.C. (USA) Founder: Level 1 Diagnostics (Cardiovascular Disease Prevention)

"As far as I am concerned the top three supplements everyone should be taking are PEOs, PEOs, and PEOs!"

- David Sim, M.D. (Interventional Cardiologist)

"This corresponds to a seventy-three percent (73%) effectiveness rating. The average improvement in arterial flexibility was 9 years improvement meaning the average subject utilizing the formulation had a cardiovascular system with the arterial flexibility of a subject representative of nearly a decade younger."

- *The late* Bernardo C. Majalca, N.D. (Stage Four Cancer Researcher)

"This is undoubtedly a breakthrough of biblical proportions.”

Testimonials may not be representative of the experience of other customers. There is no guarantee of future performance or success. No one was paid for their testimonial.

Pathways to Profits:

E-commerce and Multi-Channel Marketing 

Doctors, Physicians, and Medical Practitioners

Wholesale, Resell, and White Labeling

Sales Representatives

Company Milestones:

*More achievements & milestones coming soon*

Jan. 13, 2023

Day of Launch with DealMaker Securities LLC

Jan. 15, 2023

Minimum requirement of raising $10,000.20 completed

Jan. 19, 2023

Founder & CEO Mike Maunu presents Health Webinar to members of the 'Silicon Valley Health Institute'

Feb. 20, 2023

Company launches their 100,000 Shares of Class B Common Stock with their Give-A-Way Promotion

April 4, 2023

(Stock Give-A-Way Promotion Concludes)

1st: Nate Thorne
- 50,000 shares of Class B Common

2nd: Troy Vanderhoof
 - 30,000 shares of Class B Common

3rd: Andrew Croot
- 20,000 shares of Class B Common

May 5, 2023

Nate Thorne added to the  board of executives for Oxygen4Life™, Inc. as the new Chief Financial Officer (CFO)

June 29, 2023

Oxygen4Life™, Inc. presented and exhibited it's products at the Global Capital Network event in Newport Beach, CA.

August 1, 2023

Approved by SAM.gov, the first step to providing our products and services to government agencies and Veterans Assistance.

Company Traction:
  • Founder has been selling health products since 2002 on a part-time bases using organic traffic and word of mouth, with no advertising for his sole proprietorship.
  • Over 1,400+ past customers, medical practitioners, and wholesale resellers
  • Numerous websites, landing pages, and marketing funnels
  • ​Existing CRM database, customers & merchant account
  • ​Licensed multiple patents issued for the medicament of cancer, cardiovascular disease, and inflammation.
  • Proof of Concept in Humans - 'Investigating Dietary Lipids With Respect to Arterial flexibility'.
  • ​Case series study with an ingestible, calibrated formulation of PLANT-BASED LIPIDs (the adjuvant) at a University Wound Healing & Hyperbaric Center.
  • ​Fourteen published medical reports and three published books on PEOs and the science behind them.

INVEST IN OXYGEN4LIFE, INC. INVEST TODAY. INVEST. O4L INVEST  OUR COMPANY T.......

  • Founder has been selling health products since 2002 on a part-time bases using organic traffic and word of mouth, with no advertising for his sole proprietorship.
  • Over 1,400+ past customers, medical practitioners, and wholesale resellers
  • Numerous websites, landing pages, and marketing funnels
  • ​Existing CRM database, customers & merchant account
  • ​Licensed multiple patents issued for the medicament of cancer, cardiovascular disease, and inflammation.
  • Proof of Concept in Humans - 'Investigating Dietary Lipids With Respect to Arterial flexibility'.
  • ​Case series study with an ingestible, calibrated formulation of PLANT-BASED LIPIDs (the adjuvant) at a University Wound Healing & Hyperbaric Center.
  • ​Fourteen published medical reports and three published books on PEOs and the science behind them.
Investment Packages and Bonuses:

Invest $500 or more to receive a life-time discount and $155 in FREE Oxygen4Life™, Inc. products!

All Investments above $500 include:

- 1 bottle of PEO capsules, 
- 1 bottle of PEO liquids, 
- 1 bottle of herbal capsules, 
- 1 bottle of mineral capsules, 
- Informational pdfs, 
- Choice between the PEO Solution book or 24-Hour Diet book in digital form! $154.45 Retail Value of Products + book

$500+

(5% lifetime discount on consumer products)

+

Supplement & Book Package

$1,000+

(10% lifetime discount on consumer products)

+

Supplement & Book Package

$2,500+

(5% bonus shares + 15% lifetime discount on consumer products)

+

Supplement & Book Package

$5,000+

This package includes (1) Zoom call with Founders. 

+

(10% bonus shares + 20% lifetime discount on consumer products)

+

Supplement & Book Package with 2x the amount of product. $381.35 Retail Value

$10,000+

A day and dinner with the Founder Team in Scottsdale, AZ. and a one-night stay at a premier Hyatt Hotel.

+

(10% bonus shares + 20% lifetime discount on consumer products)

+

Supplement & Book Package with 2x the amount of product. $381.35 Retail Value

*Does not include transportation*

$25,000+

A day and dinner with the Founding Team in Scottsdale, AZ. We will fly you round-trip from anywhere in the Continental USA and will include a two-night stay at a premier Hyatt Hotel. This also will include the choice of a round of golf or a spa day.

+

(15% bonus shares + 20% lifetime discount on consumer products) - It will include a separate entry on the CAP Table. 

+

Supplement & Book Package with 2x the amount of product. $381.35 Retail Value

*Includes transportation for (1)*

$50,000+

A day and dinner for (2) the Founding Team in Scottsdale, AZ. We will fly you round-trip from anywhere in the Continental USA and will include a two-night stay at a premier Hyatt Hotel. This also will include the choice of a round of golf or a spa day.

+

(20% bonus shares + 25% lifetime discount on consumer products) - It will include a separate entry on the CAP Table. 

+

Supplement & Book Package with 2x the amount of product. $381.35 Retail Value

*Includes transportation for (2)*

Disclaimers:

* In order to receive perks from an investment, one must submit in a single investment in the same offering that meets the minimum perk requirement. Bonus shares from perks will not be granted if an investor submits multiple investments that, when combined, meet the perk requirement. All perks occur after the offering is completed.

** Investors will only receive a single bonus, which will be the highest bonus category for which they are eligible.

*** EZTREK™ is only available through a licensed medical practitioner and is not included in the product packages.

**** Lifetime discount cannot be combined with any VIP Rewards discount a customer might earn when shopping online. Choose highest discount at time of order.

***** Discounts are for retail customers only.

Meet Our Team:

Oxygen4Life's team of experts is experienced in medical sales, marketing, web development, manufacturing, graphic design, order fulfillment, and more. We specialize in providing non-drug remedies that treat the root-cause of problem, not just the symptoms.

Mike Maunu -
President & Founder

*Click here to learn more about Mike*

Alex Maunu -
Co-Founder, Director of video/content

*Click here to learn more about Alex*

Nate Thorne, E.A.  -
Chief Financial Officer (CFO)

*Click here to learn more about Nate*

Dionisio Gomez -
Director of online marketing

*Click here to learn more about Dionisio*

Ryan Cinches -
Director of Internet Technology

*Click here to learn more about Ryan*

Phil Chavanne -
Consultant in Web Design & Analytics

*Click here to learn more about Phil*

Cindi Webb -
Director of Training & Onboarding for MD's

*Click here to learn more about Cindi*

Board of Advisors:

Brian S. Peskin

Health Advisor

Professor Peskin is an unpaid Advisor and the patent owner of both the PEOs and the EZtrek® Medical Food. He is currently the President of Peskin Pharmaceuticals which was founded to research, develop, and ultimately commercialize therapeutics for disorders of the delta 6-desaturase pathway leading to increased inflammation.

Shawn O'Brien

Government Contracting Advisor

Shawn O’Brien is a seasoned professional with an extensive 25-year tenure in the US Military, Department of Defense, and The Veterans Administration, has made remarkable contributions to public service. Having retired after an impressive 21-year military career, Shawn’s exceptional dedication and commitment have been recognized including the Bronze Star Medal and Purple Heart Medal. Throughout his diverse roles in leadership, contracting, sales, and recruiting, Shawn has consistently demonstrated his expertise and versatility. 

USE OF FUNDS:

Looking for a unique investment opportunity? Look no further than Oxygen4Life™, Inc.

Since our inception in February 2022, we have been committed to reshaping the health and wellness industry through our groundbreaking products, which now include innovative medical devices and premium PEOs.

Our portfolio now features a range of advanced AI-driven health technologies, including the Smart Pulse wellness device, the FDA Cleared Class II Medical Device (Max Pulse), and the ThermaLens™ Medical Thermography Imaging System. 

These cutting-edge devices have expanded our capabilities and positioned us as pioneers in non-invasive health monitoring.

Moreover, we have strategically embarked on a government sales strategy, with products being registered on government schedules. This approach has enabled us to tap into government agencies such as the VA, DOD, HHS, and the Indian Health Services. This expansion holds immense potential for growth and market penetration.

With a robust infrastructure in place, encompassing distribution agreements, GMP-certified manufacturing, warehousing, and efficient order fulfillment, we are poised for success. Now, we are inviting investors to join us on this remarkable journey as we elevate our brand to new heights.

By investing in Oxygen4Life™, Inc. you will empower us to amplify our advertising efforts, extend the reach of our direct-to-consumer and wholesale marketing campaigns, and onboard skilled professionals to support and scale our operations. 

Our focus remains steadfast on expanding our marketing initiatives, driving sales, and establishing strategic collaborations with medical practitioners and other key players in the industry.

In tandem with enhancing our e-commerce brand, we are gearing up to implement robust systems for consistent product promotion to our target markets, widening our audience reach. This growth trajectory will be supported by the addition of new team members and interns, ensuring that we have the requisite resources to meet burgeoning consumer demand and thrive in a competitive market.

This is your chance to be part of a transformative journey that promises to reshape health and wellness. Don't miss out on this exciting opportunity to make a meaningful impact and be part of something truly exceptional. 

Your investment in Oxygen4Life™, Inc. is an investment in the future of healthcare.

It’s pioneers like YOU who can help us pave the way for different results in healthcare. 

This is the ground-floor opportunity for you to join Oxygen4Life™, Inc. as we move into our next phase of aggressive company growth. 

*Forward looking projections cannot be guaranteed*

Frequently Asked Questions:

CUSTOM JAVASCRIPT / HTML
CUSTOM JAVASCRIPT / HTML

Whitepapers and Evidence:

Adulterated vs un-adulterated Omegas

Distinguish between the effects of unadulterated (natural) forms of parent omega-6 (Linoleic Acid "LA"), versus adulterated (chemically altered) forms is vital to truly understand the beneficial effects of essential fatty acids on the  cardiovascular system. 

Importance of Digital Pulse Wave Analysis

Measurements for early cardiovascular changes are rarely performed, causing undertreatment of cardiovascular complications. Early detection and treatment of cardiovascular complications can result in reversibility of cardiac abnormalities

The I.O.W.A. Study

Long-term PEO supplementation was evaluated in thirty-four (34) subjects. Results showed the average improvement in arterial flexibility was a 9 year improvement, meaning the average subject using PEOs had the vascular system of someone almost a decade younger.

Private Clinical Study

Lead patient had a cardiac calcium score decrease by 20% and the only thing it could be attributed to was the PEOs he started taking for cancer prevention. (Study from a radiology practice which provides CT, MRI, PET and Ultrasound examinations. )
Copyrights 2023 | All Rights Reserved | Oxygen4life.com | Oxygen4Life Inc™
PRIVACY POLICY -  TERMS & CONDITIONS - BLOG
These statements have not been evaluated by the Food and Drug Administration. These products and statements are not intended to diagnose, treat, cure or prevent any disease or illness. These statements should not be taken as medical advice, you should always consult your doctor before making any health changes, decisions and/or drawing any health conclusions. 

This site is not a part of the Facebook website or Facebook Inc. Additionally, This site is NOT endorsed by Facebook in any way. FACEBOOK is a trademark of FACEBOOK, Inc.
1. E. Wainwright, Y. S. Huang, et al., “The Effects of Dietary n-3/n-6 Ratio on Brain Development in the Mouse: A Dose Response Study with Long-Chain n-3 Fatty Acids,” Lipids, vol. 27, no. 2, pp. 98-103, 1992; W. E. M. Lands, et al., “Quantitative effects of dietary polyunsaturated fats on the composition of fatty acids in rat tissues,” Lipids, vol. 25, no. 9, pp. 505-516, 1990.

2. C. V. Felton, et al., “Relation of Plaque Lipid Composition and Morphology to the Stability of Human Aortic Plaques,”
Arteriosclerosis, Thrombosis, and Vascular Biology,” Vol. 17, No 7, 1997, pp. 1337-1345.

* https://www.health.harvard.edu/heart-health/new-insights-about-inflammation
Oxygen4Life, Inc. is offering securities through the use of an Offering Statement that has been qualified by the Securities and Exchange Commission under Title III of the JOBS Act and Regulation CF. A copy of the Form C that forms a part of the Offering Statement may be obtained from: Form C

Equity crowdfunding investments in private placements, and start-up investments in particular, are speculative and involve a high degree of risk and those investors who cannot afford to lose their entire investment should not invest in start-ups. Companies seeking startup investment through equity crowdfunding tend to be in earlier stages of development and their business model, products and services may not yet be fully developed, operational or tested in the public marketplace. There is no guarantee that the stated valuation and other terms are accurate or in agreement with the market or industry valuations. Further, investors may receive illiquid and/or restricted stock that may be subject to holding period requirements and/or liquidity concerns.

DealMaker Securities LLC, a registered broker-dealer, and member of FINRA | SIPC, located at 105 Maxess Road, Suite 124, Melville, NY 11747, is the Intermediary for this offering and is not an affiliate of or connected with the Issuer. Please check our background on FINRA's BrokerCheck. DealMaker Securities LLC does not make investment recommendations. DealMaker Securities LLC is NOT placing or selling these securities on behalf of the Issuer. DealMaker Securities LLC is NOT soliciting this investment or making any recommendations by collecting, reviewing, and processing an Investor's documentation for this investment. DealMaker Securities LLC conducts Anti-Money Laundering, Identity and Bad Actor Disqualification reviews of the Issuer, and confirms they are a registered business in good standing. DealMaker Securities LLC is NOT vetting or approving the information provided by the Issuer or the Issuer itself. Contact information is provided for Investors to make inquiries and requests to DealMaker Securities LLC regarding Regulation CF in general, or the status of such investor’s submitted documentation, specifically. DealMaker Securities LLC may direct Investors to specific sections of the Offering Circular to locate information or answers to their inquiry but does not opine or provide guidance on issuer related matters.

Attributes:

CUSTOM JAVASCRIPT / HTML